AVTE - Wall Street Estimates - Aerovate Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 2.58

6.17 %

$ 74.5 M

Market Cap

-0.86

P/E

Price Target Average

907.75%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

36.92%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Aerovate Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for AVTE of $26 , with forecasts ranging from a low of $2 to a high of $65 .

AVTE Lowest Price Target Wall Street Target

2 USD -22.48%

AVTE Average Price Target Wall Street Target

26 USD 907.75%

AVTE Highest Price Target Wall Street Target

65 USD 2419.38%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free